Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 6, 1999, Pages 641-643

  Rowland, Mark ^a,b   Durrani, Naeem ^a  

^a Department of Research and Development   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Chemotherapy; Malaria; Pakistan; Plasmodium vivax; Primaquine; Refugees; Relapse

Indexed keywords

CHLOROQUINE; PRIMAQUINE;

ADOLESCENT; ADULT; AFGHANISTAN; ARTICLE; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG EFFICACY; DRUG RESISTANCE; ERYTHROCYTE; FEMALE; GEOGRAPHY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; IN VIVO STUDY; INDIA; LIFE CYCLE; LIVER; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; PAKISTAN; PARASITEMIA; PLASMODIUM VIVAX; RANDOMIZED CONTROLLED TRIAL; REFUGEE; RELAPSE; SYMPTOM; WORLD HEALTH ORGANIZATION;

PLASMODIUM VIVAX; PROTOZOA;

EID: 0033371572     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90081-0     Document Type: Article

References (24)

1. Baird, J. K. (1998). Primaquine as anti-relapse therapy for Plasmodium vivax. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 687.
2. Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C. & Hoffman, S. L. (1991). Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene, 44, 547-552.
3. Basavaraj, H. R. (1960). Observations on the treatment of 678 malaria cases with primaquine in an area free from malaria transmission in Mysore State, India. Indian Journal of Malariology, 14, 269-281.
4. Bouma, M. J., Goris, M., Akhtar, T., Khan, N. & Kita, E. (1995). Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan: implications for the use of primaquine in regional malaria control programmes. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 62-64.
5. Clyde, D. F. (1981). Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocidal drug. Bulletin of the World Health Organization, 59, 391-395.
6. Contacos, P. G., Coatney, G. R., Collins, W. E.. Briesch, P. E. & Jeter, M. H. (1974). Five day primaquine therapy - an evaluation of radical curative activity against vivax malaria infection. American Journal of Tropical Medicine and Hygiene, 22, 693-695.
7. Covell, G., Coatney, G. R., Field, J. W. & Singh, J. (1954). Chemotherapy of Malaria. Geneva: World Health Organization, Monograph Series, no. 27.
8. Garg, M., Gopinathan, N., Bodhe, P. & Kshirsagar, N. (1995). Vivax malaria resistant to chloroquine: case reports from Bombay. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 656-657.
9. Gilles, H. M. & Warrell, D. A. (1993). Bruce-Chwatt's Essential Malanology, 3rd edition. London: Edward Arnold.
10. Gogtay, N. & Kshirsagar, N. A. (1998). Primaquine as antirelapse therapy for Plasmodium vivax: a reply. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 687.
11. Gogtay, N., Garg, M., Kadam, V., Kamtekar, K. & Kshirsagar, N. A. (1998). A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 341.
12. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Ave & Nwe-Nwe-Yin (1993). Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 687.
13. Rowland, M., Hewitt, S. & Durrani, N. (1994). Prevalence of malaria in Afghan refugee villages sprayed with lambdacyhalothrin or malathion. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 378-379.
14. Rowland, M., Hewitt, S., Durrani, N., Bano, N. & Wirtz, R. (1997). Transmission and control of vivax malaria in Afghan refugee settlements in Pakistan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 252-255.
15. Roy, R. G., Chakrapani, K. P., Dhinagaran, D., Sitaraman, N. L. & Gosh, R. B. (1977). Efficacy of 5-day treatment of Plasmodium vivax infection in Tamil Nadu. Indian Journal of Medical Research, 65, 652-656.
16. Schuurkamp, G. J., Spicer, P. E., Kereu, R. K., Bulungol, P. K. & Rieckmann, K. H. (1992). Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 121-122.
17. Shah, I., Rowland, M., Mehmood, P., Mujahid, C., Raziq, F., Hewitt, S. & Durrani N. (1997). Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. Annals of Tropical Medicine and Parasitology, 91, 591-602.
18. Sharma, M. I. D., Sehgal, P. N., Vaid, B. K., Dubey, R. C., Nagendra, S., Paithne, P. K. & Joshi, M. L. (1973). Effectiveness of drug schedule being followed under the National Eradication Programme, India, for radical cure of vivax malaria cases. Journal of Communicable Diseases, 5, 167-174.
19. Sharma, R. C., Gautam, A. S., Orlov, V. & Sharma, V. P. (1990). Relapse pattern of Plasmodium vivax in Kheda District, Gujerat. Indian Journal of Malariology, 27, 95-99.
20. Singh, J., Ray, A. P., Misra, B. G. & Nair, C. P. (1954). Antirelapse treatment with primaquine and pyrimethamine. Indian Journal of Malariology, 8, 127-136.
21. Singh, N., Mishra, A. K. & Sharma, V. P. (1990). Radical treatment of vivax malaria in Madhya Pradesh, India. Indian Journal of Malariology, 27, 55-56.
22. Wernsdorfer, W. H. & Payne, D. (1988). Drug sensitivity tests in malaria parasites. In: Malaria - Principles and Practice of Malariology, Wernsdorfer, W. H. & McGregor, I. (editors). Edinburgh: Churchill Livingstone, pp. 1765-1800.
23. WHO (1966). World Health Organization Expert Committee on Malaria. Twelfth report. Geneva: World Health Organization, Technical Report Series, no. 324.
24. WHO (1990). Practical Chemotherapy of Malaria. Geneva: World Health Organization, Technical Report Series, no. 805.